583 related articles for article (PubMed ID: 19237565)
1. Crystal structure of human CDK4 in complex with a D-type cyclin.
Day PJ; Cleasby A; Tickle IJ; O'Reilly M; Coyle JE; Holding FP; McMenamin RL; Yon J; Chopra R; Lengauer C; Jhoti H
Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4166-70. PubMed ID: 19237565
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional analysis of cyclin D1 reveals p27 and substrate inhibitor binding requirements.
Liu S; Bolger JK; Kirkland LO; Premnath PN; McInnes C
ACS Chem Biol; 2010 Dec; 5(12):1169-82. PubMed ID: 20843055
[TBL] [Abstract][Full Text] [Related]
3. p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition.
Guiley KZ; Stevenson JW; Lou K; Barkovich KJ; Kumarasamy V; Wijeratne TU; Bunch KL; Tripathi S; Knudsen ES; Witkiewicz AK; Shokat KM; Rubin SM
Science; 2019 Dec; 366(6471):. PubMed ID: 31831640
[TBL] [Abstract][Full Text] [Related]
4. Incomplete folding upon binding mediates Cdk4/cyclin D complex activation by tyrosine phosphorylation of inhibitor p27 protein.
Ou L; Ferreira AM; Otieno S; Xiao L; Bashford D; Kriwacki RW
J Biol Chem; 2011 Aug; 286(34):30142-51. PubMed ID: 21715330
[TBL] [Abstract][Full Text] [Related]
5. The structure of CDK4/cyclin D3 has implications for models of CDK activation.
Takaki T; Echalier A; Brown NR; Hunt T; Endicott JA; Noble ME
Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4171-6. PubMed ID: 19237555
[TBL] [Abstract][Full Text] [Related]
6. CDK4 protein is degraded by anaphase-promoting complex/cyclosome in mitosis and reaccumulates in early G
Chen H; Xu X; Wang G; Zhang B; Wang G; Xin G; Liu J; Jiang Q; Zhang H; Zhang C
J Biol Chem; 2017 Jun; 292(24):10131-10141. PubMed ID: 28446612
[TBL] [Abstract][Full Text] [Related]
7. Conformational Equilibrium of CDK/Cyclin Complexes by Molecular Dynamics with Excited Normal Modes.
Floquet N; Costa MG; Batista PR; Renault P; Bisch PM; Raussin F; Martinez J; Morris MC; Perahia D
Biophys J; 2015 Sep; 109(6):1179-89. PubMed ID: 26255588
[TBL] [Abstract][Full Text] [Related]
8. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
Sarcevic B; Lilischkis R; Sutherland RL
J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for the modulation of CDK-dependent/independent activity of cyclin D1.
Ferrer JL; Dupuy J; Borel F; Jacquamet L; Noel JP; Dulic V
Cell Cycle; 2006 Dec; 5(23):2760-8. PubMed ID: 17172845
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of p27Kip1 regulates assembly and activation of cyclin D1-Cdk4.
Larrea MD; Liang J; Da Silva T; Hong F; Shao SH; Han K; Dumont D; Slingerland JM
Mol Cell Biol; 2008 Oct; 28(20):6462-72. PubMed ID: 18710949
[TBL] [Abstract][Full Text] [Related]
11. Identification of a conserved sequence motif that promotes Cdc37 and cyclin D1 binding to Cdk4.
Zhao Q; Boschelli F; Caplan AJ; Arndt KT
J Biol Chem; 2004 Mar; 279(13):12560-4. PubMed ID: 14701845
[TBL] [Abstract][Full Text] [Related]
12. Recent research in selective cyclin-dependent kinase 4 inhibitors for anti-cancer treatment.
Liu N; Fang H; Li Y; Xu W
Curr Med Chem; 2009; 16(36):4869-88. PubMed ID: 19929781
[TBL] [Abstract][Full Text] [Related]
13. Analysing the Effect of Mutation on Protein Function and Discovering Potential Inhibitors of CDK4: Molecular Modelling and Dynamics Studies.
N N; Zhu H; Liu J; V K; C GP; Chakraborty C; Chen L
PLoS One; 2015; 10(8):e0133969. PubMed ID: 26252490
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors.
Jeffrey PD; Tong L; Pavletich NP
Genes Dev; 2000 Dec; 14(24):3115-25. PubMed ID: 11124804
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells.
Sandhu C; Garbe J; Bhattacharya N; Daksis J; Pan CH; Yaswen P; Koh J; Slingerland JM; Stampfer MR
Mol Cell Biol; 1997 May; 17(5):2458-67. PubMed ID: 9111314
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cyclin D1/Cdk4 complexes by calcium/calmodulin-dependent protein kinase I.
Kahl CR; Means AR
J Biol Chem; 2004 Apr; 279(15):15411-9. PubMed ID: 14754892
[TBL] [Abstract][Full Text] [Related]
17. CDK2 regulation through PI3K and CDK4 is necessary for cell cycle progression of primary rat hepatocytes.
Wierød L; Rosseland CM; Lindeman B; Oksvold MP; Grøsvik H; Skarpen E; Huitfeldt HS
Cell Prolif; 2007 Aug; 40(4):475-87. PubMed ID: 17635516
[TBL] [Abstract][Full Text] [Related]
18. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
19. Dimerization of the amino terminal domain of p57Kip2 inhibits cyclin D1-cdk4 kinase activity.
Reynaud EG; Guillier M; Leibovitch MP; Leibovitch SA
Oncogene; 2000 Feb; 19(9):1147-52. PubMed ID: 10713702
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
Kim DM; Yang K; Yang BS
Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
